Share This Article:

Correlation Analysis between Mean Corpuscular Hemoglobin and Mean Corpuscular Volume for Thalassemia Screening in Large Population

Abstract Full-Text HTML Download Download as PDF (Size:2900KB) PP. 901-907
DOI: 10.4236/ajac.2014.514098    3,406 Downloads   4,110 Views   Citations

ABSTRACT

Correlation analysis between the hematological parameters mean corpuscular hemoglobin (MCH) and mean corpuscular volume (MCV) for thalassemia screening in large population was discussed. A total of 4920 peripheral blood samples of reproductive age persons were collected from Guangdong province of China. The hematological parameters MCH and MCV values of samples were first measured, and then the DNA analyses for thalassemia were conducted. All samples were composed by 4463 non-thalassemia and 457 thalassemia, and among 457 thalassemia samples, 311 were α-thalassemia, 133 were β-thalassemia, and 13 were α & β-thalassemia. In accordance with non-thalassemia, thalassemia, α-thalassemia, β-thalassemia, α & β-thalassemia and the entire group itself, a total of six sample groups were divided. The corresponding correlation coefficients between the measured MCH and MCV values for the six sample groups were 0.880, 0.968, 0.966, 0.962, 0.980 and 0.965 respectively. For the thalassemia carriers, highly significant correlation between MCH and MCV were observed. The fitting equations between MCH and MCV values were also obtained. The results indicated that the feasibility for thalassemia screening using MCV or MCH independently as parameter, and provided suitable strategy to select parameters and models for thalassemia screening in large population.

Conflicts of Interest

The authors declare no conflicts of interest.

Cite this paper

Long, X. , Fang, J. , Yao, L. , Xiao, Q. and Pan, T. (2014) Correlation Analysis between Mean Corpuscular Hemoglobin and Mean Corpuscular Volume for Thalassemia Screening in Large Population. American Journal of Analytical Chemistry, 5, 901-907. doi: 10.4236/ajac.2014.514098.

References

[1] Galanello, R., Eleftheriou, A. and Traeger-Synodinos, J. (2003) Prevention of Thalassaemias and Other Haemoglobin Disorders. Vol. 1, Team up Creations Ltd., Nicosia.
[2] Xu, X.M., Zhou, Y.Q., Luo, G.X., et al. (2004) The Prevalence and Spectrum of Alpha and Beta Thalassaemia in Guangdong Province: Implications for the Future Health Burden and Population Screening. Journal of Clinical Pathology, 57, 517-522.
http://dx.doi.org/10.1136/jcp.2003.014456
[3] Xiong, F., Sun, M., Zhang X., et al. (2010) Molecular Epidemiological Survey of Haemoglobinopathies in the Guangxi Zhuang Autonomous Region of Southern China. Clinical Genetics, 78, 139-148.
http://dx.doi.org/10.1111/j.1399-0004.2010.01430.x
[4] George, E. and Ann, T.J. (2010) Genotype-Phenotype Diversity of Beta-Thalassemia in Malaysia: Treatment Options and Emerging Therapies. The Medical Journal of Malaysia, 65, 256-260.
[5] Cao, A., Rosatelli, M.C., Monni, G. and Galanello, R. (2002) Screening for Thalassemia: A Model of Success. Obstetrics and Gynecology Clinics of North America, 29, 305-328.
http://dx.doi.org/10.1016/S0889-8545(01)00006-7
[6] He, Y.J., Yang, X.H., Ma, F.G. and Shu, J.C. (2005) The Value of the Combined Tests of Mean Corpuscular Volume, Red Cell Osmotic Fragility Test and Hemoglobin Electrophoresis for Diagnosis of Thalassemia. Chinese Journal of Laboratory Medicine, 28, 244-246.
[7] Zhang, X.H., Zhou, Y.J., Li, P.P., et al. (2006) Study on the Screening Program of Thalassemia and the Genotype and Hematologic Parameter among People of Productive Age in a Village, Nanning Guangxi. Chinese Journal of Epidemiology, 27, 769-772.
[8] Li, L.Y., Li, Q., Song, L.L., et al. (2012) The Value of MCV, MCH and HbA2 in Laboratory Screening of Thalassemia. Chinese Journal of Obstetrics and Gynecology, 47, 96-100.

  
comments powered by Disqus

Copyright © 2019 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.